Neurodegeneration caused by ER stress? - The pathogenetic mechanisms underlying AR-JP

Folia Pharmacologica Japonica

Volumn 124, Issue 6, 2004, Pages 375-382

  Takahashi, Ryosuke ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

CHIP; ER stress; Hsp70; Pael receptor

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; CYCLIN E; G PROTEIN COUPLED RECEPTOR; HEAT SHOCK PROTEIN 70; MITOGEN ACTIVATED PROTEIN KINASE P38; PAEL RECEPTOR; PARKIN; POLYGLUTAMINE; SYNAPTOTAGMIN; UNCLASSIFIED DRUG;

AUTOSOMAL RECESSIVE DISORDER; AUTOSOMAL RECESSIVE JUVENILE PARKINSONISM; CELL DEATH; DOPAMINERGIC NERVE CELL; DROSOPHILA; ENDOPLASMIC RETICULUM; GENE MUTATION; HUMAN; KNOCKOUT MOUSE; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; REVIEW; STRESS; UBIQUITINATION;

ANIMALS; CELL DEATH; ENDOPLASMIC RETICULUM; MICE; MICE, KNOCKOUT; PARKINSONIAN DISORDERS; RECEPTORS, G-PROTEIN-COUPLED; UBIQUITIN-PROTEIN LIGASES;

EID: 10944262709     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.124.375     Document Type: Review

References (37)

1. Dawson TM, Dawson VL. Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J Clin Invest. 2003;111 (2):145-151.
2. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 2004;304 (5674):1158-1160.
3. McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P. Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat Rev Neurosci. 2001;2 (8):589-594.
4. Marin I, Lucas JI, Gradilla AC, Ferrus A. Parkin and relatives: the RBR family of ubiquitin ligases. Physiol Genomics. 2004;17 (3):253-263.
5. Capili AD, Edghill EL, Wu K, Borden KL. Structure of the C-terminal RING finger from a RING-IBR-RING/ TRIAD motif reveals a novel zinc-binding domain distinct from a RING. J Mol Biol. 2004;340 (5):1117-1129.
6. Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 2000;25 (3):302-305.
7. Zhang Y, Gao J, Chung KK, Huang H, Dawson VL, Dawson TM. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci USA. 2000;97 (24):13354-13359.
8. Imai Y, Soda M, Takahashi R. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J Biol Chem. 2000;275 (46):35661-35664.
9. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425-479.
10. Sakata E, Yamaguchi Y, Kurimoto E, Kikuchi J, Yokoyama S, Yamada S, et al. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep. 2003;4 (3):301-306.
11. Imai Y, Takahashi R. How do Parkin mutations result in neurodegeneration? Curr Opin Neurobiol. 2004;14 (3): 384-389.
12. Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science. 2001;293 (5528):263-269.
13. Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J, et al. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med. 2001;7 (10):1144-1150.
14. Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell. 2001;105 (7):891-902.
15. Engelender S, Kaminsky Z, Guo X, Sharp AH, Amaravi RK, Kleiderlein JJ, et al. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat Genet. 1999;22 (1):110-114.
16. Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H. Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann Neurol. 2000;47 (4): 521-523.
17. Corti O, Hampe C, Koutnikova H, Darios F, Jacquier S, Prigent A, et al. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet. 2003;12 (12):1427-1437.
18. Huynh DP, Scoles DR, Nguyen D, Pulst SM. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum Mol Genet. 2003;12 (20):2587-2597.
19. Tsai YC, Fishman PS, Thakor NV, Oyler GA. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J Biol Chem. 2003;278 (24):22044-22055.
20. Murata S, Minami Y, Minami M, Chiba T, Tanaka K. CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep. 2001;2 (12):1133-1138.
21. Staropoli JF, McDermott C, Martinat C, Schulman B, Demireva E, Abeliovich A. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic eurons from kainate excitotoxicity. Neuron. 2003;37 (5):735-749.
22. Takahashi R, Imai Y, Hattori N, Mizuno Y. Parkin and endoplasmic reticulum stress. Ann N Y Acad Sci. 2003;991:101-106.
23. Zeng Z, Su K, Kyaw H, Li Y. A novel endothelin receptor type-B-like gene enriched in the brain. Biochem Biophys Res Commun. 1997;233 (2):559-567.
24. Donohue PJ, Shapira H, Mantey SA, Hampton LL, Jensen RT, Battey JF. A human gene encodes a putative G protein-coupled receptor highly expressed in the central nervous system. Brain Res Mol Brain Res. 1998;54 (1):152-160.
25. McCracken AA, Brodsky JL. Evolving questions and paradigm shifts in endoplasmic-reticulum-associated degradation (ERAD). Bioessays. 2003;25 (9):868-877.
26. Rutkowski DT, Kaufman RJ. A trip to the ER: coping with stress. Trends Cell Biol. 2004;14 (1):20-28.
27. Imai Y, Soda M, Hatakeyama S, Akagi T, Hashikawa T, Nakayama KI, et al. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell. 2002;10 (1):55-67.
28. Takahashi R, Imai Y. Pael receptor, endoplasmic reticulum stress, and Parkinson's disease. J Neurol. 2003;250 Suppl 3:III25-29.
29. Dong Z, Ferger B, Paterna JC, Vogel D, Furler S, Osinde M, et al. Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1. Proc Natl Acad Sci USA. 2003;100 (21):12438-12443.
30. Yang Y, Nishimura I, Imai Y, Takahashi R, Lu B. Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron. 2003;37 (6):911-924.
31. Pesah Y, Pham T, Burgess H, Middlebrooks B, Verstreken P, Zhou Y, et al. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development. 2004;131 (9):2183-2194.
32. Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA. 2003;100 (7):4078-4083.
33. Itier JM, Ibanez P, Mena MA, Abbas N, Cohen-Salmon C, Bohme GA, et al. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet. 2003;12 (18):2277-2291.
34. Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem. 2003;278 (44):43628-43635.
35. Von Coelln R, Thomas B, Savitt JM, Lim KL, Sasaki M, Hess EJ, et al. Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc Natl Acad Sci USA. 2004;101 (29):10744-10749.
36. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem. 2004;279 (18):18614-18622.
37. Haywood AF, Staveley BE. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease. BMC Neurosci. 2004;5 (1):14.